Malignant Neoplasm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients scheduled to undergo FDG-PET/CT for cancer diagnosis at Asahikawa Medical University Hospital Aged 20 years or older and capable of providing informed consent No diagnosis of severe cognitive impairment Judged to be in a stable physical and mental condition and able to undergo the study procedures No known hypersensitivity or allergy to aromatic components Provided written informed consent for participation in the study
Exclusion criteria
Exclusion criteria: History of fragrance hypersensitivity, asthma, or severe anxiety disorders that may cause adverse reactions to aroma stimulation Use of medications affecting heart rate variability e.g., beta blockers or antiarrhythmic drugs or use of cardiac devices such as pacemakers History of surgery for brain tumor or cerebral infarction Presence of psychiatric disorders or dementia that makes it difficult to appropriately answer questionnaires History of adverse reactions after consuming curry
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in appetite score measured by a visual analogue scale (VAS) before and after aroma exposure. | — |
Countries
Japan
Contacts
Asahikawa Medical University Department of Radiology